Sodium Nitroprusside Injection
Product Images NDC 70121-1189

4 FDA label images from Amneal Pharmaceuticals Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sodium Nitroprusside (NDC 70121-1189). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2 (Sodium Nitroprusside Injection 1)

2 (Sodium Nitroprusside Injection 1)
Chemical structure diagram of Sodium Nitroprusside showing a central iron (Fe) atom bound to five cyanide (CN) groups and one nitroso (NO) group, with associated sodium ions (2Na+) and water molecules (2H2O).*
FDA Label Image

1 (Sodium Nitroprusside Injection 2)

1 (Sodium Nitroprusside Injection 2)
A metabolic pathway diagram illustrating the metabolism of sodium nitroprusside. It shows interactions between sodium nitroprusside, hemoglobin (Hgb), methemoglobin, cyanide, thiocyanate, and thiosulfate, including involvement of active and inactive cytochromes, renal excretion, and the enzyme rhodanase.*
FDA Label Image

1 (Sodium Nitroprusside Injection 3)

1 (Sodium Nitroprusside Injection 3)
Label for Sodium Nitroprusside Injection 50 mg/2 mL (25 mg/mL) by Amneal Pharmaceuticals LLC, for intravenous infusion only. The label indicates a 2 mL single-dose fliptop vial with instructions to protect from light and monitor blood pressure during administration. Storage is between 20 to 25°C (68 to 77°F). Made in India, with label revision date 11-2019.*
FDA Label Image

1 (Sodium Nitroprusside Injection 4)

1 (Sodium Nitroprusside Injection 4)
Sodium Nitroprusside Injection 50 mg/2 mL (25 mg/mL) carton label from Amneal Pharmaceuticals LLC. The label indicates the product is for intravenous infusion only and must be diluted. It includes warnings to monitor blood pressure during administration and discard unused portions. The package contains a 2 mL single-dose Fliptoph vial. Manufactured by Amneal Pharmaceuticals Pvt. Ltd., India, and distributed by Amneal Pharmaceuticals LLC, NJ, USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.